InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
67,367.94
(
0.29%
)
Post# of 252642
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 45
Posts 4612
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 111217

Tuesday, 01/04/2011 2:21:34 PM

Tuesday, January 04, 2011 2:21:34 PM

Post# of 252642
ABT agrees with you:

http://www.clinicaltrials.gov/ct2/show/NCT01221298?term=abbott+hepatitis+c&rank=2

they have entered the fray with an all oral combo very similar to VRTX - PI (with booster) plus non-nuke plus rib sans interferon. notably absent is any treatment arm containing interferon (the design is open label which imo is smart to save money recruiting a positive control before you even know if DAAs + rib without interferon is a viable combination)

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up